Physician

Radiology

Dr. Barry I. Samuels, MD

Barry I. Samuels, MD works in the field of Radiology. He graduated from University of Michigan Medical School. Barry Samuels is also published. He has 37 publications published. The lastest publication: "Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.' Barry Samuels is registered with Medicare.

Publications

Cytarabine, Ki-67, and SOX11 in patients with mantle cell lymphoma receiving rituximab-containing autologous stem cell transplantation during first remission.
Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results.
Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma.
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide...
High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-...
Conservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma of the extremities: clinical and radiobiological results.
Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer.
In search of specimen adequacy in fine-needle aspirates of nonpalpable breast lesions.
Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy.
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced biliary carcinoma.
Hepatosplenic candidiasis. A manifestation of chronic disseminated candidiasis.
MR appearance of the distended iliopsoas bursa.
The present status of parathyroid thermography.
Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancer.
Imaging in candidiasis.
Her2/neu overexpression is associated with treatment failure in women with high-risk stage II and stage IIIA breast cancer (>10 involved lymph nodes) treated with high...
Superior sulcus tumors: treatment selection and results for 85 patients without metastasis (Mo) at presentation.
Pentostatin in T-non-Hodgkin''s lymphomas: efficacy and effect on CD26+ T lymphocytes.
Infusional vinorelbine in relapsed or refractory lymphomas.
Liposomal vincristine in relapsed non-Hodgkin''s lymphomas: early results of an ongoing phase II trial.
Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma.
Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma.
Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy.
Irinotecan in relapsed or refractory non-Hodgkin's lymphoma.
Irinotecan in relapsed or refractory non-Hodgkin's lymphomas. Indications of activity in a phase II trial.
Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin''s lymphoma.
Stages I-III follicular lymphoma: role of CT of the abdomen and pelvis in follow-up studies.
Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma.
Phase II study of denileukin diftitox for relapsed/refractory B-Cell non-Hodgkin's lymphoma.
A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for autologous transplantation for malignant lymphoma.
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.
Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.
Trimetrexate in relapsed T-cell lymphoma with skin involvement.
Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocyt...
Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma.
Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with...

Schools

University of Mi Med Sch
La Co Genl Hospital
Beaumont Hospital Royal Oak
UCLA Center Health Scis

Doctors Specialties

Nuclear Radiology
Radiology

Accepted Insurances

Education

William Beaumont Hospital
UCLA Medical Center
University of Southern California - LAC+USC Medical Center
University of Michigan Medical School

Hospital

University of Texas M.D. Anderson Cancer Center

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1467557256
Last Name Of The Provider	SAMUELS
First Name Of The Provider	BARRY
View All

Similar Doctors

	Dr. Gaiane M. Rauch, MD This Doctor is OpenDoctor Recommended.
	Dr. Babak M. Rejaie, MD This Doctor is OpenDoctor Recommended.
	Dr. Donald A. Podoloff, MD This Doctor is OpenDoctor Recommended.
	Dr. Siva R. Bodagala, MD This Doctor is OpenDoctor Recommended.
	Dr. Roland Cortez, MD This Doctor is OpenDoctor Recommended.
	Dr. Anupa K. Arora, MD
	Dr. Linda M. Fahr, MD This Doctor is OpenDoctor Recommended.
	Dr. David A. Gonzalez, MD
	Dr. Lilian O. Ebuoma, MD This Doctor is OpenDoctor Recommended.